The latest closing stock price for TScan Therapeutics as of February 21, 2025 is 2.17.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-793 today, roughly -1 times their original investment - a -32.58% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 346.5% above the current share price.
The TScan Therapeutics 52-week low stock price is 1.99, which is 8.3% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 5.73.
An investor who bought $1,000 worth of TScan Therapeutics stock at the IPO in 2021 would have $-793 today, roughly -1 times their original investment - a -32.58% compound annual growth rate over 4 years.
The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
The TScan Therapeutics 52-week high stock price is 9.69, which is 346.5% above the current share price.
The TScan Therapeutics 52-week low stock price is 1.99, which is 8.3% below the current share price.
The average TScan Therapeutics stock price for the last 52 weeks is 5.73.